ARTICLE | Clinical News
NGAL Test regulatory update
August 1, 2011 7:00 AM UTC
FDA accepted for review a 510(k) application from BioPorto for its NGAL Test to diagnose acute kidney injury. The in vitro test that detects the lipocalin ( LCN2; NGAL) biomarker produced in the kidn...